Address
Zygogen LLC
520 Kell Hall
24 Peachtree Center Avenue
Atlanta
GA 30303
USA
Email: amy@zygogen.com
Current Opinion in Drug Discovery & Development 2003 6(2):218-223
Current Drugs ISSN 1367-6733
The study of zebrafish, a leading model organism for developmental biology, is rapidly expanding to include human disease. Zebrafish models based on known disease mechanisms have been developed in several therapeutic areas, including blood diseases, diabetes, muscular dystrophy, neurodegenerative disease, angiogenesis and lipid metabolism. This review summarizes recent progress in disease model development, and outlines the potential of zebrafish to contribute to drug discovery through the identification of novel drug targets, validation of those targets and screening for new therapeutic compounds.
Keywords Disease models, drug screening, target identification, target validation, zebrafish
